HomeCompareSCPPF vs JNJ

SCPPF vs JNJ: Dividend Comparison 2026

SCPPF yields 2.97% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $6.3K in total portfolio value· pulled ahead in Year 8
10 years
SCPPF
SCPPF
● Live price
2.97%
Share price
$0.34
Annual div
$0.01
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.2K
Annual income
$359.27
Full SCPPF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — SCPPF vs JNJ

📍 JNJ pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCPPFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCPPF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SCPPF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCPPF
Annual income on $10K today (after 15% tax)
$252.23/yr
After 10yr DRIP, annual income (after tax)
$305.38/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $3,732.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCPPF + JNJ for your $10,000?

SCPPF: 50%JNJ: 50%
100% JNJ50/50100% SCPPF
Portfolio after 10yr
$27.3K
Annual income
$2,554.57/yr
Blended yield
9.35%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SCPPF
Analyst Ratings
1
Buy
2
Hold
Consensus: Hold
Altman Z
0.9
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCPPF buys
0
JNJ buys
0
No recent congressional trades found for SCPPF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCPPFJNJ
Forward yield2.97%2.14%
Annual dividend / share$0.01$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$24.2K$30.5K
Annual income after 10y$359.27$4,749.88
Total dividends collected$3.3K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: SCPPF vs JNJ ($10,000, DRIP)

YearSCPPF PortfolioSCPPF Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,997$296.74$10,594$274.49+$403.00SCPPF
2$12,071$304.97$11,294$360.69+$777.00SCPPF
3$13,229$312.87$12,133$476.91+$1.1KSCPPF
4$14,476$320.45$13,156$635.42+$1.3KSCPPF
5$15,817$327.70$14,432$854.61+$1.4KSCPPF
6$17,259$334.64$16,056$1,162.76+$1.2KSCPPF
7$18,808$341.25$18,175$1,604.53+$633.00SCPPF
8← crossover$20,472$347.56$21,009$2,252.68$537.00JNJ
9$22,259$353.56$24,911$3,229.73$2.7KJNJ
10$24,176$359.27$30,458$4,749.88$6.3KJNJ

SCPPF vs JNJ: Complete Analysis 2026

SCPPFStock

S4 Capital plc, together with its subsidiaries, operates as a digital advertising and marketing services company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Content, Data & Digital Media, and Technology Services. The company offers contents, campaigns, and assets for paid, social, and earned media, such as digital platforms and apps, as well as brand activations. It also provides campaign management analytics, creative production and ad serving, platform and systems integration and transition, and training and education services. In addition, the company offers digital transformation services in delivering digital product design, engineering services, and delivery services. S4 Capital plc is headquartered in London, the United Kingdom.

Full SCPPF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SCPPF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCPPF vs SCHDSCPPF vs JEPISCPPF vs OSCPPF vs KOSCPPF vs MAINSCPPF vs ABBVSCPPF vs MRKSCPPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.